The Lessons of QUANTEC: Recommendations for Reporting and Gathering Data on Dose-Volume Dependencies of Treatment Outcome

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3 SUPPL., 2010, Pages

  Jackson, Andrew ^a   Marks, Lawrence B ^b   Bentzen, Søren M ^c   Eisbruch, Avraham ^d   Yorke, Ellen D ^a   Ten Haken, Randal K ^d   Constine, Louis S ^e   Deasy, Joseph O ^f  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endpoint definition; Normal tissue toxicity; Statistical reporting standards

Indexed keywords

DOSE DISTRIBUTIONS; DOSE-VOLUME; DOSE-VOLUME ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; META-ANALYSIS; NORMAL TISSUE TOXICITY; STATISTICAL REPORTING; TREATMENT OUTCOMES;

STANDARDS;

TOXICITY;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL PRACTICE; HISTOGRAM; HOSPITALIZATION; HUMAN; ORGAN SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIATION PNEUMONIA; RADIATION RESPONSE; RATING SCALE; TREATMENT OUTCOME;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; META-ANALYSIS AS TOPIC; RADIATION INJURIES; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 76449087147     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.074     Document Type: Article

References (43)

1. Bentzen S. Towards evidence based radiation oncology: Improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 46 (1998) 5-18
2. Trotti A., and Bentzen S. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 22 (2004) 19-22
3. Wong C., Van Dyk J., Milosevic M., et al. Radiation myelopathy following single courses of radiotherapy and retreatment. Int J Radiat Oncol Biol Phys 30 (1994) 575-581
4. Jackson A., Yorke E., and Rosenzweig K. The atlas of complication incidence: A proposal for a new standard for reporting the results of radiotherapy protocols. Semin Radiat Oncol 16 (2006) 260-268
5. Schultheiss T.E. Spinal cord radiation tolerance. Int J Radiat Oncol Biol Phys 30 (1994) 735-736
6. Hope A.J., Lindsay P.E., Naqa I.E., et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65 (2006) 112-124
7. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
8. Kong F.-M., Hayman J., Griffith K., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
9. Pan C.C., Eisbruch A., Lee J.S., et al. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 61 (2005) 1393-1402
10. Jackson A., Skwaarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer (II): Volume effects and dose-volume histograms. Int J Rad Oncol Biol Phys 49 (2001) 685-698
11. Tucker S.L., Liu H.H., Wang S., et al. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66 (2006) 754-761
12. Jackson A. Partial organ irradiation of the rectum. Seminars Radiat Oncol 11 (2001) 215-223
13. Jackson A., Yorke E.D., Rosenzweig K.E., et al. EUD and dose-volume based atlases of complication incidence: A proposal for new standards in reporting results of treatment protocols [abstract]. ASTRO 2006 Philadelphia, PA; 2006. Int J Radiat Oncol Biol Phys 66 S3 (2006) S124-S125
14. Jackson A., Ten Haken R.K., Robertson J.M., et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31 (1995) 883-891
15. Wei L.J. Testing goodness of fit for proportional hazards model with censored observations. J Am Stat Assoc 79 (1984) 649-652
16. Hae H., and Lee S. Comparison of goodness of fit tests for the cox proportional hazards model. Comm Stat Simulat Comput 29 (2000) 187-206
17. Le C., Zelterman D., and Le C. Goodness of fit tests for proportional hazards regression models. Biometrical J 34 (1992) 557-566
18. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika 67 (1980) 145-153
19. Skwarchuk M., Jackson A., Zelefsky M., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phy 47 (2000) 103-113
20. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
21. Kupelian P., Reddy C., Carlson T., et al. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: Absolute or relative rectal volume?. Cancer J Sci Am 8 (2002) 62-66
22. Fenwick J.D., Khoo V.S., Nahum A.E., et al. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys 49 (2001) 473-480
23. Koper P.C., Heemsbergen W.D., and Hoogeman M.S. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1072-1082
24. Garcia-Vincente F., Zapatero A., Floriano A., et al. Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancer. Med Phys 32 (2005) 2503-2509
25. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
26. Levegrun S., Jackson A., Zelefsky M., et al. Risk group dependence of dose response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol 63 (2002) 11-26
27. Bradley J., Hope A., Naqa I.E., et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 69 (2007) 985-992
28. Tucker S., Liu H., Liao Z., et al. Analysis of radiation pneumonitis risk using a generalized Lyman model. Int J Radiat Oncol Biol Phys 72 (2008) 568-574
29. Heemsbergen W.D., Hoogeman M.S., Hart G.A., et al. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1011-1018
30. Peeters S.T., Lebesque J.V., and Heemsbergen W.D. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
31. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
32. Schilstra C., and Meertens H. Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland. Int J Radiat Oncol Biol Phys 50 (2001) 147-158
33. Blanco A.I., Chao K.S., and Naqa I.E. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1055-1069
34. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
35. Eisbruch A., Ship J.A., Kim H.M., et al. Partial irradiation of the parotid gland. Semin Radiat Oncol 11 (2001) 234-239
36. Jellema A.P., Doornaert P., Slotman B.J., et al. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 (2005) 164-171
37. Saarilahti K., Kouri M., Collan J., et al. Erratum to "sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer" [Radiother. Oncol. 78 (2006) 270-275]. Radiother Oncol 80 (2006) 107-108
38. Saarilahti K., Kouri M., Collan J., et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 78 (2006) 270-275
39. LENT SOMA. Tables: Table of contents 1995. Radiother Oncol 35 (1995) 17-60
40. Overgaard J., and Bartelink H. About tolerance and quality. An important notice to all radiation oncologists. Radiother Oncol 35 (1995) 1-3
41. Pavy J.-J., Denekamp J., Letschert J., et al. EORTC late effects working group. Late effect toxicity scoring: The SOMA scales. Radiother Oncol 35 (1995) 11-15
42. Rubin P., Constine L.S., Fajardo L.F., et al. RTOG late effects working group: Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35 (1995) 9-10
43. Denekamp J., Bartelink H., Rubin P., et al. Correction for the use of the SOMA LENT tables. Radiother Oncol 39 (1996) 191